1Kennedy HL,Brooks MM,Barker AH,et al.Beta-blocker therapy in the Cardiac Arrhymia Suppres-sion Trial[].The American Journal of Cardiology.1994
2Fassbinder W,Quarder O,Waltz A.Treat-ment with carvedilol is associated with a significant reduction in microalbuminuria:a multi2centre ran-domized study[].Int J Cli n Pract.1999
3TIMS Study Group.Agnes E,Vandermercken C,Prost J-F,Safar M.The Tertatolol International Multicenter Study.(TIMS)Predicting factors of an ef-ficient therapy[].American Journal of Hypertension.1989
5Palatini P,Julius S.Heart rate and the cardiovascular risk[].Journal of Hypertension.1997
6Palatini P,Julius S.Pathophysiology ofthe association between increased heart rate and car-diovascular morbidity and mortality[].Medicographia.2002
7HOT Study Group.Effects of intensive blood-pressure lowering and low-dose aspirin in pa-tients with hypertension:principal results of the Hy-pertension Optimal Treatment(HOT)randomised trial[].The Lancet.1998
8Singh B N,Signh N.What is the future of agents that specifically reduce heart rate[].Medicographia.2002
9Gillman MW,Kannel WB,Belanger A,et al.Influence of heart rate on motality among persons with hypertension:the framinhan study[].American Heart Journal.1993
10Lindholm LH,Carlberg B,Samuelsson O.Shouldβblockers remain first choice in the treat-ment of primary hypertension?A meta-analysis[].The Lancet.2005
